Enhance
electrochemotherapy
efficacy in dogs and cats
For the palliative treatment of: Squamous cell carcinoma. Lymphomas (Hodgkin’s and non-Hodgkin’s). Soft tissue sarcomas. Used in electrochemotherapy to enhance therapeutic efficacy in dogs and cats.
Targeted Relief for Complex Veterinary Cancers
Oncobleomin is a sterile lyophilized powder containing Bleomycin for Injection USP 15 Units, developed specifically for veterinary use.
It is indicated for the palliative management of various malignancies in dogs and cats, including squamous cell carcinoma, lymphomas (both Hodgkin’s and non-Hodgkin’s), and soft tissue sarcomas.
In addition to conventional administration, Oncobleomin is commonly used in electrochemotherapy protocols to enhance local drug uptake and improve treatment outcomes. Its targeted mechanism of action, combined with favorable tolerability, makes it a valuable option in veterinary oncology.
- Enhance electrochemotherapy efficacy
- For dogs and cats
- Reliable Quality from Celon Labs
Provide advanced palliative care for your oncology patients with a trusted chemotherapeutic agent.
Leaflet
About Celon Labs
Celon is a leader in the development and marketing of specialty products which serve niche therapy areas including oral and injectable Oncology and Critical Care.
Celon Laboratories Private Limited started its operations in 2007 with an exclusive focus on Oncology and steadily progressed towards another therapy area – Critical Care. With a strong growth oriented approach, in a short span, Celon has made its presence felt in India and the ROW markets.
Contact Us
We’d love to hear from you
Whether you have questions about Oncobleomin or need support with veterinary oncology treatments, our team at Celon Labs is here to assist you. Let’s work together to deliver better care for your patients.
(123) 1234-567-891
Contact Us
Copyright © 2025 Oncobleomin